1. [Inhaled treatments: Choice of devices, systemic absorption of inhaled drugs and bitter taste receptors in the respiratory tract].
- Author
-
Benattia A, Cavaillon P, Gachelin E, Devillier P, Vecellio L, Williams G, and Dubus JC
- Subjects
- Aerosol Propellants, Aerosols, Animals, Anti-Infective Agents administration & dosage, Anti-Infective Agents pharmacokinetics, Bronchodilator Agents administration & dosage, Bronchodilator Agents pharmacokinetics, Chemistry, Pharmaceutical, Equipment Design, Expectorants administration & dosage, Expectorants pharmacokinetics, Humans, Insulin administration & dosage, Insulin pharmacokinetics, Macrophages drug effects, Macrophages physiology, Muscle Relaxation drug effects, Myocytes, Smooth Muscle drug effects, Myocytes, Smooth Muscle physiology, Nebulizers and Vaporizers classification, Receptors, G-Protein-Coupled drug effects, Receptors, G-Protein-Coupled physiology, Respiratory System drug effects, Tissue Distribution, Vasodilator Agents administration & dosage, Vasodilator Agents pharmacokinetics, Taste Receptors, Type 2, Administration, Inhalation
- Abstract
Inhaled drugs are now routinely prescribed in daily medical practice. Recent topics about these treatments have been developed during the fourth annual meeting of the Groupe de travail aérosolthérapie (GAT) of the French-speaking respiratory society (Société de pneumologie de langue française). This article focuses mainly upon the choice of devices, systemic absorption of inhaled drugs and bitter taste receptors in the respiratory tract, a potential new target for drug development., (Copyright © 2014 SPLF. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF